pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-215 |
Genomic Coordinates | chr1: 220117853 - 220117962 |
Synonyms | MIRN215, miRNA215, mir-215, MIR215 |
Description | Homo sapiens miR-215 stem-loop |
Comment | This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-215-3p | |||||||||||||||||||||
Sequence | 64| UCUGUCAUUUCUUUAGGCCAAUA |86 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | AP4E1 | ||||||||||||||||||||
Synonyms | CPSQ4, SPG51, STUT1 | ||||||||||||||||||||
Description | adaptor related protein complex 4 epsilon 1 subunit | ||||||||||||||||||||
Transcript | NM_007347 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on AP4E1 | |||||||||||||||||||||
3'UTR of AP4E1 (miRNA target sites are highlighted) |
>AP4E1|NM_007347|3'UTR 1 CAGAAGCCCTGCTAAATTTTACTCCATCAAGATCAATGGTTTACATAGATAAACTTATTTACCAAAGTAAAAAGAACTCA 81 TGGTACTTCTAATGAAAATGGGGATTATTACAAGTGTGGTTTATATGTTTTCTTTGTGATTCCTGGTCAAGAAAGATCCC 161 CAAAACTGTATCCCTAACCTTTAACTCAGGATTGTACAGTATGTTTAGGTCCCTCAAAAAGTGACCTAAGCTAATGTTAT 241 AAACTGCTAATGATTTATATATCACTTAGTGTGTAGAGGGACTGAAAATATTTATTTTGTTATAAATAATTTTATAGCAC 321 GTTTACTCTAGTGCTAGCTAATTTGTAATAAAGCCAAGTCTCAGTTTTCTGCATTAAATGGAAGGGAGACATGAAATTGA 401 TAATCTCAAACTTAATTCATATTTGGCTTTGGAATGTAGTGTATGGTTTTTGGTAGGGAAGTCAATATTTTCGATTATGT 481 TTTGCTTAGATCAGTGTTGAACTAAGTTGGCATAGCACACACTAACAGTTGTAGGAGATCCATGAGCATGCTGGATATTG 561 AGGGGATCCAATCTGTGATCTATTTTTTATTATAGATAACTGTTACACATAATTTCAGATCGTTTGGCTGTAAAATTTGT 641 CTGTTTTCCACTTGGAGTTATTTTAAAATTCAAAGTAAATCACTCTATTCTTATTTTGAAAACTCAGAGCCATTTTATAT 721 AGAAACAAAACCCATAAGAGCACACAGTAACAAAGCAAACAGATACAAAAATGACTTTTTAGTTATGACAAATATTTTAG 801 TTGGTTACTACTTAGGTCCTTTTGGCAAATGAAAATTTGTGATTAGAGTATAAATGGCAAAACTATCTTTTCCTGGCCTT 881 TGAATCCACTAGTACTTAATGGATATAGCTGAAGCAGAGACTAAGTATAACATACAGGTTCTTCAGTAAAATATATCATT 961 TTCATGTTATAGTTATGCCTGTGTGGCCTCTGTCAGAACTATTATCAGTAAAAGAGGTTAAGCCTATATATGAATGATGG 1041 ACCAAAACCTTGAGGTTGTACATTAACTGAAATAGTATTTTATAAAATCTTATGGTGCTGTGGAAAATATTTATTATTTC 1121 ACCTTTTCTGACACTTCACCATGGAGACTATTCAGGTAATACAATTTTAAGTCATTGCAGTTAATACTCTGGTTAATTGG 1201 TACTGTTAATCACCCAGGTCAGGAATTCTGATTTTAGGTTATCTCATTAATCATGGCTGATAAAGAAGCTAAGGGGATTC 1281 TCCAGATCTAATAGATTTCATTAGTCATTTGTGTCGAGTATTCCTCCCTAAAAACAAAAGCAGTATTTTCTTTCTCAATT 1361 AATTTTTAAGTTATTCATTAAAAAATATATAACATCTTAATTTTATTCTTTTAAAAACATACAGTGAAGCCTTGCTACAA 1441 GAGTCATAAGTGACTGGAATTTCTTGCATAATAGGTTCCTCCTTTTGAATAGATCAGATTCATCCCCAGGCTCTCAGCAG 1521 TGTCATGATGAAATGAGTGTGCTGACTTCAGGGGTGTGGTGGACACTGGTAGCTAGCCTTATCAGCTCCCTCCTTATTCC 1601 TACCTCTGTCAGCAGCATGCCTCGCCCCTTACCTAATTCTGCTGTGACTCTGACAGAGAGGAAGTGCCTTCTCACTTTGC 1681 AAAGGAATGCAGCATGTCACAAAGGAGGTGCTCCAATTTTTTGTGTCCTTACTTCCCTATGTTTGCCTAGTTACTGAGGC 1761 TAGGTCGAGTGTGAAGCAATAGGTGTAAGATGCTGAGAGCACATGGACAGCTACCAGGGAGATCTGTTGCTTGGTTACAG 1841 GGTGTATTCATGAGTGGTAGCTGCAGTTGTCGTGAGAGACATGCTTGGCATACAGAGCTGTCTAATGGGTGGGAGACATG 1921 TAATGGTAGATTTAGGGCTGGGAGCATGATTTTGGGTCTGCCCAAAGGAACATGGTGTCACTTTTGTTCTTTCTGACCCA 2001 CTAAATAAAAAGTAGTGTAACAGGGTTTCACTGGAATGTTTATTAGAAAGTTTACACTTTTTATATTTTTATGATTTTAA 2081 AAACAAACAATAATAGAAAAACAGATTTTAAGGAACTTCAGAGCAGTATATATTCTGTCTAAACTCACTGAATATTTTAA 2161 GTTGTAAATCAGGTGTCCACCAACCTTTATTTTTGCATTGCAGGAGATGTGACTGTAAAGTAGGGAGTTTTTTTTTTTGA 2241 GACAGAGTTTCACCCTTGTTGCCCAGGCTAGAGTGTAATGGTGCAATCTCCGCTCACTGCAACCTCTGCCTCCCAGGTTC 2321 AAGCGATTCTCCTGCCTCAGCCTCCCTAGTAGCTGGGATTACAGGCATGCACCACCACACCCGGCTAATTTTTTTATATT 2401 TTTAGTAGAGACAAGGTTTCTCCATGTTGGTCAGGCTGGTCTCGAACTCCCGACCTCAGGTGATCTGCCCGCCTCAGCCT 2481 CCCAAAGTGCTGGGATTACAGGCGTGAGCCACTGCGCCCGGCCAAATTATTTTTGTGGGTAGATTCATTCTCTTTACCTA 2561 ATAGTCATAATTTAGTCAGTGAAGGGACAACATCTGGGGTAAGAGCTATGGAGGAGGTGCTCAGCTTTGTGAGTTTTGTG 2641 CCAGGCATCTTTGCTGAAAATGGAGATGGCAGCAAGTGTGAATCTGGGGGAATATAAGGGAAGACAGAAAAGCCTTAAGA 2721 GTAGACGGAGGAAGAAGGGTACCAGAATAGTCCCTGTGGAGGCAGGCAGATCAGAGCTCAGGGTTTGAAAGTGGGCCTGA 2801 GTAAGGGTCCTGCTAGAGAAACTGCAGATGGAAGCTGAGCAGTTACCAACTGCTAATGTGCCAAGTATACCAAGCACAGC 2881 ATGTGTCCTGTAGAGGAGCATTATTTTAAACAATGTTCTACTATCATCTACCAAAATAATTGTGGTAAAAGTGTAGTATT 2961 TTATTTTTTCCTTTTATGTCAGCAATATTTTAAAATATTGATCTGTTTATCTTATATTTTTATGGATAAATGTAGTATTT 3041 GCCTCATGATTGTGAGCCACTGAGAGTGCACTGAACCTATTCACATGTCTTTAAGATGTTTTGCTGTGTTAAAATTTTAG 3121 GAGAGAAAAATACAAGTGAATAATTATTTAATAGGCATTTATTACTTTATTTTGGAGTTGAATTCTGTCATTTGAAAAAG 3201 TTCAGTAATGTAATAAATACAAAGTGATCTGCACTGTTAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000261842.5 | 3UTR | CCCCUUACCUAAUUCUGCUGUGACUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
96 hsa-miR-215-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT058509 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT445625 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT449286 | RPP14 | ribonuclease P/MRP subunit p14 | 2 | 2 | ||||||||
MIRT456702 | LDB1 | LIM domain binding 1 | 2 | 2 | ||||||||
MIRT467723 | SLC38A1 | solute carrier family 38 member 1 | 2 | 2 | ||||||||
MIRT474253 | LATS2 | large tumor suppressor kinase 2 | 2 | 2 | ||||||||
MIRT481811 | AP4E1 | adaptor related protein complex 4 epsilon 1 subunit | 2 | 2 | ||||||||
MIRT491969 | USP37 | ubiquitin specific peptidase 37 | 2 | 2 | ||||||||
MIRT513203 | RFT1 | RFT1 homolog | 2 | 2 | ||||||||
MIRT532737 | CMTM6 | CKLF like MARVEL transmembrane domain containing 6 | 2 | 2 | ||||||||
MIRT535706 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT536138 | MAPK14 | mitogen-activated protein kinase 14 | 2 | 2 | ||||||||
MIRT536463 | KLF12 | Kruppel like factor 12 | 2 | 4 | ||||||||
MIRT552615 | ZBTB8A | zinc finger and BTB domain containing 8A | 2 | 2 | ||||||||
MIRT554011 | SPIRE1 | spire type actin nucleation factor 1 | 2 | 2 | ||||||||
MIRT563259 | SLC29A1 | solute carrier family 29 member 1 (Augustine blood group) | 2 | 2 | ||||||||
MIRT571054 | POLQ | DNA polymerase theta | 2 | 4 | ||||||||
MIRT573556 | TMEM120B | transmembrane protein 120B | 2 | 2 | ||||||||
MIRT573772 | PRKAG1 | protein kinase AMP-activated non-catalytic subunit gamma 1 | 2 | 2 | ||||||||
MIRT575328 | Fbxo6 | F-box protein 6 | 2 | 2 | ||||||||
MIRT575497 | Sept3 | septin 3 | 2 | 5 | ||||||||
MIRT607051 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT607070 | POM121L7 | POM121 transmembrane nucleoporin like 7 pseudogene | 2 | 2 | ||||||||
MIRT607497 | HEBP2 | heme binding protein 2 | 2 | 2 | ||||||||
MIRT607799 | RHBDL2 | rhomboid like 2 | 2 | 2 | ||||||||
MIRT610832 | COL9A1 | collagen type IX alpha 1 chain | 2 | 2 | ||||||||
MIRT616853 | DSG2 | desmoglein 2 | 2 | 2 | ||||||||
MIRT617154 | C18orf42 | A-kinase anchor inhibitor 1 | 2 | 2 | ||||||||
MIRT620823 | MKI67IP | nucleolar protein interacting with the FHA domain of MKI67 | 1 | 1 | ||||||||
MIRT625698 | OPTN | optineurin | 2 | 2 | ||||||||
MIRT628082 | KAT7 | lysine acetyltransferase 7 | 2 | 2 | ||||||||
MIRT633540 | PGBD5 | piggyBac transposable element derived 5 | 2 | 2 | ||||||||
MIRT634343 | SGOL1 | shugoshin 1 | 2 | 2 | ||||||||
MIRT634605 | KIAA1919 | major facilitator superfamily domain containing 4B | 2 | 2 | ||||||||
MIRT636759 | SLC16A5 | solute carrier family 16 member 5 | 2 | 2 | ||||||||
MIRT637044 | SEPT3 | septin 3 | 2 | 7 | ||||||||
MIRT637213 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT639634 | ZSCAN23 | zinc finger and SCAN domain containing 23 | 2 | 2 | ||||||||
MIRT640818 | GPR107 | G protein-coupled receptor 107 | 2 | 2 | ||||||||
MIRT641033 | PITPNB | phosphatidylinositol transfer protein beta | 2 | 2 | ||||||||
MIRT641545 | MOCOS | molybdenum cofactor sulfurase | 2 | 2 | ||||||||
MIRT642091 | FBXL2 | F-box and leucine rich repeat protein 2 | 2 | 2 | ||||||||
MIRT645528 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT647017 | ADCY2 | adenylate cyclase 2 | 2 | 2 | ||||||||
MIRT648044 | FADS6 | fatty acid desaturase 6 | 2 | 2 | ||||||||
MIRT648514 | PIGG | phosphatidylinositol glycan anchor biosynthesis class G | 2 | 2 | ||||||||
MIRT648869 | ABCA6 | ATP binding cassette subfamily A member 6 | 2 | 2 | ||||||||
MIRT656722 | LMLN | leishmanolysin like peptidase | 2 | 2 | ||||||||
MIRT658260 | FAXC | failed axon connections homolog | 2 | 2 | ||||||||
MIRT659063 | DEPTOR | DEP domain containing MTOR interacting protein | 2 | 2 | ||||||||
MIRT659364 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | 2 | 2 | ||||||||
MIRT660318 | BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | 2 | 2 | ||||||||
MIRT663345 | ZNF74 | zinc finger protein 74 | 2 | 2 | ||||||||
MIRT663526 | MASTL | microtubule associated serine/threonine kinase like | 2 | 2 | ||||||||
MIRT663975 | ZNF786 | zinc finger protein 786 | 2 | 2 | ||||||||
MIRT664354 | C16orf45 | chromosome 16 open reading frame 45 | 2 | 2 | ||||||||
MIRT664473 | ZYG11B | zyg-11 family member B, cell cycle regulator | 2 | 2 | ||||||||
MIRT664975 | TDRD1 | tudor domain containing 1 | 2 | 2 | ||||||||
MIRT665488 | VPS53 | VPS53, GARP complex subunit | 2 | 2 | ||||||||
MIRT667758 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | 2 | 2 | ||||||||
MIRT669552 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT670183 | CCDC142 | coiled-coil domain containing 142 | 2 | 2 | ||||||||
MIRT671342 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT671873 | ZNF429 | zinc finger protein 429 | 2 | 2 | ||||||||
MIRT672018 | PXMP4 | peroxisomal membrane protein 4 | 2 | 2 | ||||||||
MIRT672068 | KIAA0930 | KIAA0930 | 2 | 2 | ||||||||
MIRT672551 | BRMS1L | breast cancer metastasis-suppressor 1 like | 2 | 2 | ||||||||
MIRT672849 | ICOSLG | inducible T-cell costimulator ligand | 2 | 2 | ||||||||
MIRT672988 | KBTBD6 | kelch repeat and BTB domain containing 6 | 2 | 2 | ||||||||
MIRT673088 | AK1 | adenylate kinase 1 | 2 | 2 | ||||||||
MIRT673578 | KDELC2 | KDEL motif containing 2 | 2 | 2 | ||||||||
MIRT674582 | SLC35B4 | solute carrier family 35 member B4 | 2 | 2 | ||||||||
MIRT674999 | STRN3 | striatin 3 | 2 | 2 | ||||||||
MIRT675596 | ZNF106 | zinc finger protein 106 | 2 | 2 | ||||||||
MIRT675778 | YIPF4 | Yip1 domain family member 4 | 2 | 2 | ||||||||
MIRT676029 | C9orf69 | transmembrane protein 250 | 2 | 2 | ||||||||
MIRT679015 | MTMR10 | myotubularin related protein 10 | 2 | 2 | ||||||||
MIRT679169 | PSMB2 | proteasome subunit beta 2 | 2 | 2 | ||||||||
MIRT687413 | NRIP1 | nuclear receptor interacting protein 1 | 2 | 2 | ||||||||
MIRT688038 | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 2 | 2 | ||||||||
MIRT691644 | SLC43A3 | solute carrier family 43 member 3 | 2 | 2 | ||||||||
MIRT695630 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT697562 | ZBTB10 | zinc finger and BTB domain containing 10 | 2 | 2 | ||||||||
MIRT699153 | SMC1A | structural maintenance of chromosomes 1A | 2 | 2 | ||||||||
MIRT699683 | SFMBT2 | Scm like with four mbt domains 2 | 2 | 2 | ||||||||
MIRT702177 | LYRM4 | LYR motif containing 4 | 2 | 2 | ||||||||
MIRT706217 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 2 | ||||||||
MIRT711243 | TRAT1 | T-cell receptor associated transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT712343 | NLN | neurolysin | 2 | 2 | ||||||||
MIRT716574 | HOPX | HOP homeobox | 2 | 2 | ||||||||
MIRT717443 | TENM1 | teneurin transmembrane protein 1 | 2 | 2 | ||||||||
MIRT717759 | KCNRG | potassium channel regulator | 2 | 2 | ||||||||
MIRT717945 | TUBD1 | tubulin delta 1 | 2 | 2 | ||||||||
MIRT718343 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT718773 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 | ||||||||
MIRT737073 | FOXM1 | forkhead box M1 | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|